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Quir,idine is a widely used drug in the management of’ 
supraventricular and ventricular arrhythmias. Its pharmaco- 
logic effects are camp 
on myocardium is co 
erties, which may be ~rlorn~~e~t in those regions of the heart 
where a high density of autonomic receptors is found (8-4) 
Similar to all a~t~arr~~~~tlmic drugs, quinidine may exacer- 
bate or cause new arrhythmias &IO), of which ventricular 
forms are most thrcdtening. There is thus interest in the 
mechanisms causing these deleterious effects. 
The overall eifects of quinidine on QT interval duration 
and ventricular electrophysiologic properties have been 
widely investigated (I), but little attention has been given to 
distinguishing between direct and autonomically mediated 
activity at this site. This lack is probably due to incomplete 
knowledge of the autonomic effects on the ventricular elec- 
trophysirrlogic substrate in humans, which, in tu:n, makes it 
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diflicult to devise suitable stk:dy dcsgm. 
inance cf cholinergic tone on 53th QT interva 
ventricuiar refractoriness h23 been r 
cently. vie wed that in healthy 
relation is a ted by vagal tone, ir!depend 
the sympathetic limb (151; namely, in the range o& 
hysio?ogic cycle lengths {between 4% and 6% ms), CX 
QT Sirration in the b;s$ condition was increasingly more 
prolonged as heart rate decl-eaxlj than it was atier with- 
drawal of autonomic t:lne. In the Fresent sttddy, the direct 
an3 vagolytic actions of quinidine on ventricular suMaPe 
were investigated in a similar model, which enabled us to 
analyze events occurring on ventricular repolarization after 
abrupt increases in heart rate. The RWQT relation after 8 
beats of l\a;ed cycle lengths between 6 
assessed in 15 patients, both in the basal state and after 
autonomic blockade, before and a *,er pral 
istration. 
Fifteeri patier?ts [mr:an age -C- SD 57.1 2 14 years: nine 
men and six women] referred to our center for evaluation Of 
pdroxysmal supraventricular tachyarrhythmiaz were re- 
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cruited for the study, which was part cf an dectrQp~Ysio- 
logic investigation to define the mechanisms of arrhythmias 
and the antiarrhythmic therapy needed to treat hem. Six 
patients had a cardiovascular disease (hypertensive in five, 
vdvular in one, all in New York Heart Association func- 
tional class I). In three patients, minor abnormalities of E/A 
ratio were found at Doppler velocimetry across the mitral 
valve. Dizziness was reported in six patients and near 
syncope in two. The underlying arrhythmias were found to 
be atrioventricular (AV) reciprocating tachycardia in five 
patients, atrial fibrillation i seven, atria1 tachycardia in two 
and atria1 flutter in one. 
All patients had a normal basal and corrected QT interval. 
Electrolytes and triiodothyronine and thyroxine values were 
within ormal range at the time of the study. All cardioactive 
medication a d drugs having effects either on the autonomic 
system or on QT duration were terminated before catheter- 
ization for a period exceeding 5 half-lives of any agent. 
After informed consent was obtained from all patients, 
the two electrophysiologic studies were periormed in the 
postabsorptive, nonsedated state. For atriai pacing, aquad- 
ripolar catheter was used; pacing was performed using a 
custom-designed battery-powered stimulator producing 
square wave impulses of 2-ms duration at twice diastolic 
threshold. 
Requirements forpatient selection i cluded the following 
criteria: I) absence of previous myocardial infarction; 2) I : 1 
AV node conduction up to a cycle length ~500 ms; 3) narrow 
QRS complex; 4) clearly detectable T waves; 5) absence ofa 
U wave: 6) intrapat nt QT intervals available for compari- 
sons in ail four cone Jns (basal state, autonomic blockade, 
basal state plus quiniiine and autonomic blockade plus 
quinidine) and in three or more of the assessed pacing 
lengths. Evahtation of the RWQT relation after propranolol 
infusion was hampered by a Wenckebach block occurring a,t 
a cycle length >500 ms in nine patients in the first study 
(control study) and in all patients inthe second study, after 
quinidine administration. 
patients with previous myocardial infarction were ex- 
cluded because major changes inthe autonomic substrate of 
such patients (16) could a$ect interpretation of data. 
Lead II was used for QT measurement ineach patient. 
The QT interval was measured from the onset of the Q (or R) 
wave to the termination of the T wave, which was deter- 
mined by the intersection f the T wave and the isoe!ectric 
baseline. Measurements were performed by three separate 
investigators. Two replicate measurements weremade by 
each reader, 
During atria1 pacing, I: 1 AV node conduction was main- 
tained for eight complexes. The QT interval was measured in 
the last paced beat and in the same lead before and after drug 
interventions. In the control study, the QT interval was 
measured in each patient during atria! pacing at six different 
Pacing Iengths (600,540,500,460,430 and 400 ms) during the 
basal state. This protocol was repeated 15 min after the 
administration f intravenous propranoioi and again 5 min 
after intravenous atropine (0.04 mglkg). The whole protocol 
was completed within 25 min after atropine a~rn~~~st~atio~. 
Electrocardiographic leads I, !I, !:I and V, as well as 
intracardiac recordings (frequency range 30 to 5 
simultaneously recorded on a rn~~t~cba~~~el Hewlett-Packard 
oscilloscopi,: recorder at a paper speed of 100 mm/s. 
A comparison f the QT interval among the three di 
ent conditions (i.e., basal state, after beta-adrenerg~c and 
after autonomic blockade) was made at each of the six cycle 
lengths used. 
At the end of the first study, oral quinidine was ad&G+ 
tered at the daily dosage of 1,200 mg. The second study was 
performed after 3 to 4 days of q~i~~dj~e administrative using 
the same protocol as in the control study. 
Regression curves estimating the correlation between 
pacing cycle length aud QT duration were drawn for each 
patient during the basal state and after autono 
both in the control stl,dy and in the steady state after 
quinidine administiation. Differences in mean slopes of 
regression curves were finally assessed. For purposes of 
clarity throughout this study, the e~ectr~pbysiologic vari-
ables assessed during the basal state are indicated as “bas- 
al,” whereas those assessed after autonomic blockade are 
indicated as “intrinsic.” 
At the b+inning of the second study, blood samples were 
taken for tt;:: determination f serum quinidine levels (ther- 
apeutic range 2to 5 nglml). 
ysis 
The dependence of QT duration on cycle length was 
analyzed by file-- 1 at regression analysis in each of the four 
conditious. Intraobserver variability on QT measurements 
(i.e., variability of replicate measurements by a single ob- 
server) was assessed with the Student r test. Comparison of
mean slopes of the RWQT relation and interobserver vari- 
ability on QT measurements was achieved by a two-way 
analysis of variance (17,18) and Student t test with Drncan’s 
correction when appropriate. Data are presented as mean 
values + SEM. Paired observation f sinus cycle length and 
QT interval in the various conditions, as well as quinidine- 
induced changes in QT duration, were tested with the 
Wiicoxon test for paired ata nd presented as mean value + 
SD. 
ts 
In the control study, the mean basal sinus cycle !cngth 
increased from 938 It 254 to 1,052 + 253 ms (p < 0.001) after 
beta-blockade and decreased to 793 c 152 ms (p < 0.01) after 
autonom blockade, thus exhibiting a relative predomi- 
rnance of the cholinergic limb onheart rate at rest. After 
therapy with quinidiwe, the mean basal sinus cycle length 
increased from 928 or. 182 to 1,051 rt 187 ms (p c 0.01) after 
beta-blockade butwas unchanged after autonomic blockade, 
Before Quinldine Aher Quinidine 
--. 
Basal Aher After Auk3m1ic Basal Aftts ABes Aueonom~s 
State Beta-Blockade Blockade Slate Sela-P!ockAe Blochde 
429 A.15 ?W 4% 4&4 469 
386 439 411 :so 495 :a 
418 432 377 440 447 411; 
355 312 338 405 430 418 
369 318 360 412 441 42% 
398 384 370 464 472 4-B 
386 393 350 459 461 454 
411 415 l/B *I, AA9 498 467 
467 505 442 473 468 4% 
338 349 326 430 440 41s 
327 346 307 371 368 353 
340 368 323 424 469 4% 
381 388 360 416 431 402 
479 503 442 533 530 485 
368 379 336 400 415 410 
390 a?$ 367 441 457 439 
averaging 915 + 142 s (p = NS), thus showing a drmg- 
related vagolytic activity in rest conditions. 
The basal CT innerval inc 
50 ms (p .‘: 0.01) after beta-b! 
41 ms (p < 0.01) after auton 
administration, the basal QT interval increased fr 
40 to 457 + 39 ms (p < 
autonomic blockade, aver 
(Table I ). 
In the control study, t 
creased from 4 
beta-blockade an 
autonomic blockade (p = NS). After quinidine administra- 
tion, the basal QTc interval decreased from 463 + 28 to 448 
It 24 ms after beta-blockade (p < 0.01) but showed little 
change after autonomic blockade, averaging 459 ? 26 ms 
(p = NS). 
The relation between atrial pacing length and QT duration 
was assessed for each patient. In the control study, the 
correIation i dex ranged ?om 0.91 to 0.99 in basal conditions 
and from 0.7 to 1 after wirhdraw:: ;f autonomic influences; 
after ~~i~~di~e admi~istrat~o~~, the correlation i dex ranged 
from 0.9 to 1 in the basal state and from 0.91 to 0.99 after 
autonomic blockade. 
In the control study, the mean slope of th regression 
curve estimating the correlation between cycle .ength and 
Q’T duration ie? the basal state decreased from 0.27 + 0.10 to 
0.14 + 0.05 after autonomic blockade (p < 0.05) (Fig. I). 
After quinidine administration, the mean basal slope of the 
regression curve average 
igure 1. Regression li es showing correlation between pacimg 
ycle length (CL) api QT interval s assessed in each patient during 
the basal stale and Gter autonomic (Auton.) blockade in the sonrrol 
study; b = meal! slope drawn from single slopes obtained foreach 
patient. 
QT interval (ms) 
440, 
320 - 
, I I I 0 
400 4330 460 5co 540 600 s 
CL (ms) CL @as) 
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Basal state 
ii = 0.20~0.07 
Auton. blockade 
5 = 0.19 + 0.05 
d__ , , , , r 
400 430 ;ygrIy 540 600 400 430 gO55y 540 600 
Figure 2, Regression lines showing correlation between pacing 
cycle length and QT interval as assessed in each patient during the 
basal state and after autonomic blockade after oral quiuidine admin- 
istration. Abbreviations as in Figure I. 
drug-related change in QT duration increased progressively 
from 42 zt 17 to 48 L IS ms (p < 0.05) during the basal state 
and decreased progressively from 65 2 19 to 59 + I9 ms 
(p < 0.05) after autonomic blockade (Fig. 3). This same trend 
was observed in the nine patients inwhom all measurements 
were available inthe range between 600 and 460 ms (from 
42 ? i6 io 49 + i7 ms during the basal staie and from 68 -f: 
I7 to 59 + 18 ms after autonomic blockade). The degree of 
drug-related change in QT duration after autonomic block- 
ade was Agnificantly greater than that during the basal state 
at all cycle lengths but tended to reduce with shorter cycles. 
Variation in QT measurement did not differ significantly 
60 
50 
40 
30 
20 
10 
n 
Figure 3. Changes in QT interval tion after quinidine adminis- 
tration during the basal state ( bars) and after autonomic 
blockade (dark bars) in the t&al study group. The degree of 
di:tg-related change after autonomic blockade is significantly greater 
than during the basal state at all cycle lengths (Ch) bat tends to 
decrease with shorter cyclc~,. 
either among observers orwhen replicate measurement was 
made by the same reader. 
Quinidine prolonged the basal I=W interval duration from 
46 c 5 to 49 + 6 ms (p < 0.05) and prolonged the intrinsic 
HV interval to a similar extent, fro 
(p c 0.05). The drug also prolonged 
from 91 t 7 to 100 + 9 ms (p < 0.001) and the intrinsic 
duration from 90 2 7 to 98 + 9 ms (p < 0.0011. No major 
rate-dependent changes inthis variabie were found in any of 
the four conditions examined. The plasma quinidine concen- 
trations ranged from 1.9 to 4 ngiml (mean 2.7 2 0.6). 
Table 2. Slopes of Regression Curves as Assessed in Each Patient in the Basal State and After 
Autonomic Blockade, Both in the Control Study and After Quinidine Administration 
Case 
I 
‘) . 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
I2 
I3 
I4 
I5 
Mean 
SEM 
p value 
Basal 
State 
0.269 
0.108 
0.388 
0.100 
0.280 
0.408 
0.264 
0.220 
0.322 
0.218 
0.241 
0.222 
0.243 
0.493 
0.220 
0.27 
0.10 
Before Quinidine 
After Autonomic 
Blockade 
0.221 
0.117 
0.145 
0.058 
0.141 
0.151 
0.134 
0.135 
0.128 
0.121 
0.124 
0.100 
0.175 
0.2% 
0.107 
0.14 
0.05 
Basal 
State 
0.213 
0.180 
0.243 
0.179 
0.194 
0.191 
0,072 
0.189 
0.271 
OJM 
0.187 
0.119 
0.170 
0.384 
0.197 
0.20 
0.07 
After Quinidine 
After Autonomic 
Blockade 
0.227 
0.197 
0.243 
0.184 
0.172 
0.197 
0.131 
0.180 
0.296 
0.179 
0.200 
0.134 
0.105 
0.250 
0.222 
0.19 
0.05 
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T interval, exerts tw 
rt bursts of atrial 
s between 400 and 
range, dynamic ~~teract~o~s between heart rate and auto- 
nomic neural activities on the QT i 
interpretation f true observable m asurements. This model 
also accolmts for extrapoiation to clinical situations in which 
sudden changes in heart rate are likely to result in a potential 
arrhythmogenic effect. Finally, it must be noted that auto- 
nomic withdrawal was achieved here with a stepwise infu- 
sion of propranolol and atropine; thus, any di~ere~ce ob- 
served between basal condition an 
blockade is attributable to a cholinergi 
dent of sympathetic modulation. This pot 
nt experimental data (25) providing clear 
nou,;ced effect of acetylcholine to either 
y abbreviate action potential duration and 
Urn. 
01 T Ix!. 
lation. In the present study, quinidine was associated with a 
direct prolonging effect on ventricular repolarization. I  fact, 
the mean duration of the basal QT interval at any cycle 
length was significantly higher after drug administration. 
Moreover, the drug increasingly prolonged the intrinsic, but 
not the basal, QT duration as heart ate decreased (Fig. 3). 
One might speculate hat in some patients with latent ven- 
tricular epolarization abnormalities (9), a quinidine-related 
nonmriform increase in repolarization could be generated in 
response tolong diastolic intervals (26) or long-short activa- 
tion sequences (27), thus creating the conditions for deve!- 
opment of li e-threatening arrhythmias. 
Although concealed in basal conditions owing to the 
vagolytic effects of quinidine, reverse use dependence might 
ies or latent [9] 
myocardial infarction (B-30). pharmacologic as well as 
surgical a~t~a~re~erg~c interventions hav 
redtrce the incidence ofsudden cardiac deat 
ischemic heart disease (39-49). 
models indicate that vagal stimula 
macological~y or electrically (42), can effectively prevent 
ventricular fibrillation. On the basis of these observations, 
autonomic properties of a~tia~bytbm~c drugs have recently 
been thought to be a possible cause of fatal arrhyth 
ged as heart rate decreased fro 
n it was after a~t~~~~l~c blo kade. 
because mean slopes of regression curves assessed in the 
basal condition and after autonomic blockade were si 
In the present study, in 6 of 15 patients it was possible to 
compare slopes in the basal state and after beta-blockade 
during the control study, and their mean values were similar. 
It could therefore be deduced that in the present control 
study, a direct cholinergic nfluence was the 
of the differences in WQT relation observ 
ic blockade in this patient 
t model, comparison of mean slopes of 
regression curves in the basal state l&r-e and afte 
dine administration allowed interpretatmr of auton 
teraction between thedrug and the ner~,ous system. Ora! 
quinidine significantly decreased the basal mean slope Of the 
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WQT relation, thus exhibiting autonomic activity that 
counteracts the effect of cholinergic prevalence on such 
relations in ba.sai conditions. Owing to the methods used 
here (namely, pharmacolo,., CG beta-blockade systematically 
preceding atropine infusion), quinidine autonomic effects in 
this setting can be either vagolytic or sympathomimetic. 
p.!!hough both mechanisms have been attributed toquinidine 
(3,43), the latter has been related to its parenteral dminis- 
tqtion as a counterregulating mechanism in response to 
systemic hypotension (44,45). In this study, quinidine was 
administered orally, and no episode of hypotension was 
documented; however, although unlikely, a sympathomi- 
metic effect could not be excluded efinitively because 
assessment of the effect of quinidine-sympathr& interac- 
tions on the RWQT relation was hampered in all palients by 
the occurrence of Wenckebach block at cycle lengths 
i500 ms after beta-biockade, uring the second elecrrophys- 
iologic study. 
The main effect of reduced basal slope in the RWQT 
relation curve after quinidine was that reverse use depen- 
dence was thus masked; it was only after autonomic block- 
ade that comparison of mean slopes before and after drug 
administration allowed evidence ofreverse use dependence. 
Therefore, the autonomic properties of quinidine clearly 
counteract its direct activity on ventricular repolarization 
after an abrupt increase in heart rate in the range xplored 
here. 
Potential limitations of this study. Some limitations ofour 
study should be mentioned. 1)It was not possible to measure 
QT interval duration at all six pacing cycle lengths at each of 
the four states in all patients because of the occurrence of
Wenckebach block at a cycle length of <460 ms in six 
patients and at a cycle length of ~500 ms in six other 
patients. This limitation was circumvented byrigorous com- 
parison of mean slopes obtained from single slopes assessed 
within the same range of cycle lengths in all four states. 
2) In the present model we used short bursts of atrial 
stimulation. Because it is uncertain whether repolarization 
has stabilized after 8 beats, the results hown here should 
not be extrapolated to a longer period f time. 
3) Accuracy in measuring QT interval duration may be 
less than that in measuring the QRS complex; some b;as 
should therefore be taken into account with any method 
applied to assessment of QT duration. Previous reports (46) 
have shown that no particular lead influences the interob- 
server variability inQT interval measurement. I  he present 
study, the same bipolar lead was used for intrapatient 
comparison in the four states. Neither autonomic manipula- 
tion nor quinidine administration resulted in major changes 
in the QRS complex and the T axis; therefore, it is reason- 
able to assume that a similar degree of accuracy was 
maintained when measuring the same variable from the same 
lead in the di!Ter,ent states. Although inierlead variation of 
the QT interval has been recently examined as a measure of
QT dispersion (471, this factor did not appear to meet he 
strict requirements of the present protocol because there are 
inadequate r ported ata on its reproducibility and oi; the 
influence ofautonomic manipulation. 
4) The slightly heterogeneous di ease state of the 15 
patients could have enced some of the results. Patients 
with mild organic h
minimize this, and only three patients exbi 
tional abl:ormalities at echocardiography. This limitation 
applies to many studies dealing with supraventricular ar-
rhythmias requiring anti imens. 5) The direct 
and autonomically mediat 
dine were assessed atthe 
treatment; whether such effects are still presen 
long term 
Signific 
cations both for the sp 
ular tissue and for the era1 approach to a better under- 
standing ofthe clinical cts of a~t~arrhythm~c drugs, with 
a particular view to proarrhythmic a tivity. 
By distinguishing direct and autonomically mediated ef- 
fects of oral quinidine, we found two previously unreported 
effects of the drug on ventricular re~olarizatio~ n the clinical 
setting: 1) a reverse use dependence activity on he RRIQT 
relation, 2) an autonomic property that counteracts the effect 
of vagal tone on this relation during basal conditions. These 
indicate two potentially undesirable 
could play a proarrhythmic role dur 
and further emphasize the nead for direct pharmacologic 
research for more ideal antiarrhythmic agents. If drugs can 
be developed that delay repolarization a d prolong refracto- 
riness selectively at the acterizing clinical 
yarr~ytbmias, their e greatly improved 
and their tendency to develop roarrhythmic effects would 
be reduced. The absence of vagolytic, if not vagotonic, 
activity would also be desirable inthe ideal antiarrhythmic 
agent. 
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